Alzamend Neuro, Inc. 9ZT0.F Stock
Alzamend Neuro, Inc. Price Chart
Alzamend Neuro, Inc. 9ZT0.F Financial and Trading Overview
| Alzamend Neuro, Inc. stock price | 0.14 EUR |
| Previous Close | 0.6 EUR |
| Open | 0.61 EUR |
| Bid | 0.62 EUR x N/A |
| Ask | 0.62 EUR x N/A |
| Day's Range | 0.61 - 0.61 EUR |
| 52 Week Range | 0.28 - 1.48 EUR |
| Volume | 2K EUR |
| Avg. Volume | 35 EUR |
| Market Cap | 59.52M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9ZT0.F Valuation Measures
| Enterprise Value | 52.8M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 10.065574 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Alzamend Neuro, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -20.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.48 EUR |
| 52 Week Low | 0.28 EUR |
| 50-Day Moving Average | 0.51 EUR |
| 200-Day Moving Average | 0.76 EUR |
9ZT0.F Share Statistics
| Avg. Volume (3 month) | 35 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 96.94M |
| Float | 67.35M |
| Short Ratio | N/A |
| % Held by Insiders | 41.53% |
| % Held by Institutions | 7.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | April 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -92.19% |
| Return on Equity (ttm) | -173.29% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -15442037 EUR |
| Diluted EPS (ttm) | -0.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.38M EUR |
| Total Cash Per Share (mrq) | 0.08 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.185 |
| Book Value Per Share (mrq) | 0.061 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8250323 EUR |
| Levered Free Cash Flow (ttm) | -3616520 EUR |
Profile of Alzamend Neuro, Inc.
| Country | Germany |
| State | GA |
| City | Atlanta |
| Address | 3500 Lenox Road NE |
| ZIP | 30326 |
| Phone | 844 722 6333 |
| Website | https://www.alzamend.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Q&A For Alzamend Neuro, Inc. Stock
What is a current 9ZT0.F stock price?
Alzamend Neuro, Inc. 9ZT0.F stock price today per share is 0.14 EUR.
How to purchase Alzamend Neuro, Inc. stock?
You can buy 9ZT0.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Alzamend Neuro, Inc.?
The stock symbol or ticker of Alzamend Neuro, Inc. is 9ZT0.F.
Which industry does the Alzamend Neuro, Inc. company belong to?
The Alzamend Neuro, Inc. industry is Biotechnology.
How many shares does Alzamend Neuro, Inc. have in circulation?
The max supply of Alzamend Neuro, Inc. shares is 7.32M.
What is Alzamend Neuro, Inc. Price to Earnings Ratio (PE Ratio)?
Alzamend Neuro, Inc. PE Ratio is 0.00000000 now.
What was Alzamend Neuro, Inc. earnings per share over the trailing 12 months (TTM)?
Alzamend Neuro, Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the Alzamend Neuro, Inc. company belong to?
The Alzamend Neuro, Inc. sector is Healthcare.